Search

everythinglearnresearchcommunity

for

Search:↓

Chromium supplements don't help with weight loss or improve hormone and metabolism issues in people with polycystic ovary syndrome.

High triglyceride levels are a key factor affecting testosterone levels in women with PCOS.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

The internet has accurate information on Polycystic Ovarian Syndrome, but it's not high quality or easy to read, so we need better, user-friendly resources.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

About 6.5% of young Caucasian women in Spain have polycystic ovary syndrome.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Hormonal treatments can help with acne but are not the first choice due to side effects and the need for careful patient selection.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Women with polycystic ovarian syndrome are more likely to have cervical insufficiency, especially South Asian and Black women.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Polycystic ovary syndrome is a common hormonal disorder in women, linked to increased risk of metabolic and heart diseases, and needs more research for better understanding and treatment.

The study concluded that androstendione and DHEA are important for diagnosing high male hormone levels in women with excessive hair growth.

About 5% of Thai university girls aged 17-19 have polycystic ovary syndrome, with moderate acne being a strong risk factor.

Irregular menstrual cycles in exercising women may be linked to energy deficiency or hormonal imbalances, requiring careful diagnosis for proper treatment.

Low birthweight and rapid weight gain after birth may increase the risk of developing polycystic ovary syndrome.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

HSD3B1 gene variant and being overweight linked to hair loss in women with polycystic ovary syndrome.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

A certain genetic variation is linked to a higher risk of polycystic ovarian syndrome.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

A teenage girl had both a rare ovarian tumor and a severe form of polycystic ovarian syndrome.